Predictors of respiratory failure in patients with Guillain–Barré syndrome: a systematic review and meta‐analysis

2018 ◽  
Vol 208 (4) ◽  
pp. 181-188 ◽  
Author(s):  
Cameron Green ◽  
Tess Baker ◽  
Ashwin Subramaniam
Keyword(s):  
Systematic Review ◽  
Respiratory Failure ◽  
Meta Analysis ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

scholarly journals Guillain-Barré syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype

2020 ◽  
Vol 14 (4) ◽  
pp. e0008264 ◽  
Author(s):  
Sonja E. Leonhard ◽  
Cristiane C. Bresani-Salvi ◽  
Joanna D. Lyra Batista ◽  
Sergio Cunha ◽  
Bart C. Jacobs ◽  
...  
Keyword(s):  
Systematic Review ◽  
Virus Infection ◽  
Zika Virus ◽  
Meta Analysis ◽  
Guillain Barre Syndrome ◽  
Zika Virus Infection ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

scholarly journals COVID-19 infection complicated by Guillain-Barre Syndrome: a systematic review of clinical features, pathogenic mechanism, and respiratory failure

2021 ◽  
Vol 9 (1) ◽  
pp. 34-34
Author(s):  
Mahya Khaki ◽  
Parastoo Dehghan ◽  
Naghmeh Malekzadeh ◽  
Mohsen Khamoushi ◽  
Fahimehalsadat Shojaei ◽  
...  
Keyword(s):  
Systematic Review ◽  
Respiratory Failure ◽  
Clinical Features ◽  
Case Reports ◽  
Case Series ◽  
Diagnostic Workup ◽  
Guillain Barre Syndrome ◽  
World Health ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

Background: The World Health Organization (WHO) declared a pandemic in March 2020 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the neurotropism feature of the coronavirus and growing number of COVID-19 associated neurological disorders, including Guillain Barre syndrome (GBS), we conducted a systematic review to thoroughly describe the clinical features, diagnostic workup, and clinical outcome of COVID-19 associated GBS in 78 cases. Methods: We identified case reports and case series of COVID-19 associated GBS by conducting a search in the PubMed/MEDLINE and EMBASE databases. We assessed the quality of studies using an appraisal checklist presented by Cochrane Murad et al. Extracted data included demographic characteristics, clinical presentation, diagnostic workup, and outcome. Results: The systematic search yielded a total of 60 articles reporting 78 patients with a diagnosis of COVID-19 associated GBS. The patients were mainly male (65.3%) with an average age of 57 years. The ascending symmetrical paresis was the most common presentation (79.4%), with demyelinating pattern in 54 patients (79.4%). The CSF analysis showed albuminocytologic dissociation in 48 patients (75%). The mortality of COVID-19 associated GBS was estimated as 6.4% attributable to progressive respiratory failure. Conclusion: Given the associated morbidities such as respiratory failure in patients with COVID-19 associated GBS, its timely detection is crucial to prevent poor clinical outcomes. On the other hand, clinicians must be vigilant to identify the clinical findings of SARS-CoV-2 infection in newly diagnosed GBS patients, as this might be a neurological complication of the subclinical viral infection.

scholarly journals Is an Increased Risk of Developing Guillain–Barré Syndrome Associated with Seasonal Influenza Vaccination? A Systematic Review and Meta-Analysis

Vaccines ◽  
2020 ◽  
Vol 8 (2) ◽  
pp. 150 ◽  
Author(s):  
Marek Petráš ◽  
Ivana Králová Lesná ◽  
Jana Dáňová ◽  
Alexander M. Čelko
Keyword(s):  
Systematic Review ◽  
Influenza Vaccination ◽  
Influenza A ◽  
Seasonal Influenza ◽  
Meta Analysis ◽  
Epidemiological Studies ◽  
Guillain Barre Syndrome ◽  
Increased Risk ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

While the weight of epidemiological evidence does not support a causal link with influenza vaccination evaluated over the last 30 years, Guillain–Barré syndrome (GBS) has been considered a vaccine-associated adverse event of interest since 1976. To investigate the existence of GBS risk after vaccination against seasonal influenza, a systematic review and meta-analysis have been conducted based on 22 eligible epidemiological studies from 1981 to 2019 reporting 26 effect sizes (ESs) in different influenza seasons. The primary result of our meta-analysis pointed to no risk of vaccine-associated GBS, as documented by a pooled ES of 1.15 (95% CI: 0.97–1.35). Conversely, an obvious high risk of GBS was observed in patients with previous influenza-like illness (ILI), as demonstrated by a pooled ES of 9.6 (95% CI: 4.0–23.0) resulting from a supplementary analysis. While the meta-analysis did not confirm the putative risk of vaccine-associated GBS suggested by many epidemiological studies, vaccination against seasonal influenza reduced the risk of developing ILI-associated GBS by about 88%. However, to obtain strong evidence, more epidemiological studies are warranted to establish a possible coincidence between vaccination and ILI prior to GBS onset.

scholarly journals Prevalence of Guillain-Barré syndrome among Zika virus infected cases: a systematic review and meta-analysis

2018 ◽  
Vol 22 (2) ◽  
pp. 137-141 ◽  
Author(s):  
Ludovica Barbi ◽  
Antonio Victor Campos Coelho ◽  
Luiz Cláudio Arraes de Alencar ◽  
Sergio Crovella
Keyword(s):  
Systematic Review ◽  
Zika Virus ◽  
Meta Analysis ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré
Sign in / Sign up

Export Citation Format

Share Document